Ascendis Pharma A/S (ASND) Stock Price Today
Overview
Financial
Technicals
Analysis
Corporate Action
About
About Ascendis Pharma A/S
Ascendis Pharma A/S is a biopharmaceutical company. It develops prodrug therapies with profiles to address large markets with significant unmet medical needs with its Transcon technology. The firm's product pipeline includes Transcon growth hormone, Transconpeptides, Transcon PTH, Transcon CNP, and others. It operates mainly in North America, Germany, China, and Denmark and derives the majority of its revenue from China.
Technical Indicators
|
|
|
Bearish (7)
Neutral (11)
Bullish (9)
Performance
ASND ROI
% from 52W High
52W Low: $86.1
04 Oct 2023
52W High: $159.4
23 Feb 2024
News
People Also Bought
US Stocks risk is managed by PT PG Berjangka which has a license from the Badan Pengawas Perdagangan Berjangka Komoditi (BAPPEBTI), and your investment is guaranteed by the Jakarta Futures Exchange (JFX) and the Indonesian Clearing House (KBI). Read our product’s Terms and Conditions. View Terms and Conditions
Let’s trade or invest in this asset by signing up or logging in!
You can also download our app!
